Form D · Biotechnology
Adarza BioSystems, Inc.
St. Louis, MO · CIK 0001570716
Offering snapshot reported Feb 6, 2020 · SEC filing
- Reported sold
- $12.8M Offering amount: $26.6M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 21, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 6, 2020 | Initial | $12,776,884 | No comparison | 7 | SEC filing |
| Jan 16, 2018 | Amendment | $10,854,876 | $5,771,519vs Jan 31, 2017 | 16 | SEC filing |
| Jan 31, 2017 | Initial | $5,083,357 | No comparison | 7 | SEC filing |
| Mar 28, 2016 | Initial | $4,865,384 | No comparison | 19 | SEC filing |
| Jul 3, 2014 | Initial | $2,000,000 | No comparison | 13 | SEC filing |
| Jul 10, 2013 | Amendment | $959,066 | No comparison | 10 | SEC filing |
| Mar 11, 2013 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-359887
Source: Form D, filed Feb 6, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Scott Bernstein | Director |
| Charles Bolton | Director |
| Heiner Dreismann | Director |
| Teryl Gronwall | Executive |
| Randolph R. Henke | Promoter |
| Brian Hopcraft | Director |
| Andrew Jay | Director |
| John Mckearn | Director |
| John Mc Kearn, Ph.D. | Director |
| Linda Meeh | Executive |
| Benjamin Miller | Director |
| Larry Page | Director |
| Jenny Rooke | Director |
| Jay Schmelter | Director |
| James Senall | Director |
| David Smoller | Director |
| Christopher Striemer | Executive |
| Bryan Witherbee | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2184 Welsch Industrial Court
St. Louis, MO, 63146
St. Louis, MO, 63146